Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer.-论文-万方医学网

第一作者： Cesare,Gridelli

第一单位： Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.

作者： Cesare,Gridelli ^[1] ; Antonio,Rossi ^[1] ; Massimo,Di Maio ^[2] ; Silvana,Leo ^[3] ; Virginio,Filipazzi ^[4] ; Adolfo G,Favaretto ^[5] ; Marco A,Burgio ^[6] ; Saverio,Cinieri ^[7] ; Roberto,Bianco ^[8] ; Fortunato,Ciardiello ^[9] ; Luigi,Cavanna ^[10] ; Roberto,Bordonaro ^[11] ; Raffaele,Costanzo ^[12] ; Claudia,Sandomenico ^[12] ; Ciro,Gallo ^[13] ; Francesco,Perrone ^[14] ; Alessandro,Morabito ^[12]

作者单位： Medical Oncology, S.G. Moscati Hospital, Avellino, Italy. ^[1] Clinical Trials Unit, Istituto Nazionale Tumori Fondazione G. Pascale-IRCCS, Napoli, Italy. ^[2] Medical Oncology, Vito Fazzi Hospital, Lecce, Italy. ^[3] Medical Oncology, Sacco Hospital, Milano, Italy. ^[4] Medical Oncology 2, Istituto Oncologico Veneto-IRCCS, Padova, Italy. ^[5] Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-IRCCS, Meldola (FO), Italy. ^[6] Medical Oncology, A.Perrino Hospital, Brindisi, Italy; IEO Istituto Europeo di Oncologia-IRCCS, Milano, Italy. ^[7] Medical Oncology, Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Napoli, Italy. ^[8] Medical Oncology, Second University, Napoli, Italy. ^[9] Medical Oncology, Guglielmo da Saliceto Hospital, Piacenza, Italy. ^[10] Medical Oncology, Garibaldi Nesima Hospital, Catania, Italy. ^[11] Thoraco-pulmonary Medical Oncology, Istituto Nazionale Tumori-Fondazione Pascale IRCCS, Napoli, Italy. ^[12] Medical Statistics, Department of Mental Health and Preventive Medicine, Second University, Napoli, Italy. ^[13] Clinical Trials Unit, Istituto Nazionale Tumori Fondazione G. Pascale-IRCCS, Napoli, Italy. Electronic address: francesco.perrone@usc-intnapoli.net. ^[14]

主题词腺癌(Adenocarcinoma);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);顺铂(Cisplatin);脱氧胞苷(Deoxycytidine);女(雌)性(Female);随访研究(Follow-Up Studies);谷氨酸盐类(Glutamates);鸟嘌呤(Guanine);人类(Humans);肺肿瘤(Lung Neoplasms);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);肿瘤分期(Neoplasm Staging);预后(Prognosis);前瞻性研究(Prospective Studies);生活质量(Quality of Life);研究设计(Research Design);存活率(Survival Rate)

DOI 10.1016/j.cllc.2013.11.011

PMID 24418693

发布时间 2022-12-07

检索历史清除

Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer.

Clinical lung cancer

相似文献

Clinical lung cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer.

Clinical lung cancer

相似文献

Clinical lung cancer

相关期刊

检索历史清除